Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
350 participants
OBSERVATIONAL
2016-12-31
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of MiRNA 371 in Patients with Germ Cell Tumors
NCT04435756
Circulating microRNAs in Small Testicular Masses and Retroperitoneal Post-chemotherapy Residual Masses.
NCT06620016
Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors
NCT02303015
Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors
NCT01572467
miRNAs in High Grade Serous Ovarian Cancer
NCT05146505
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biomarker analysis
Blood collection. Blood samples will be collected at diagnosis, during surveillance, during treatment and every 3-6 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients diagnosed with testicular germ cell cancer.
* Age 18-70 years of age.
* Must be able receive information and to consent.
Exclusion Criteria
* Other diseases or conditions that hinder the ability to receive information and to participate in follow-up procedures.
18 Years
70 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karolinska University Hospital
OTHER
Sahlgrenska University Hospital
OTHER
Helse Fonna
OTHER
University Hospital of North Norway
OTHER
Oslo University Hospital
OTHER
Haukeland University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mette Pernille Myklebust, PhD
Role: PRINCIPAL_INVESTIGATOR
Haukeland University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haukeland University Hospital
Bergen, , Norway
Haugesund Hospital
Haugesund, , Norway
Oslo University Hospital
Oslo, , Norway
University Hospital of North Norway
Tromsø, , Norway
Sahlgrenska University Hospital
Gothenburg, , Sweden
Karolinska University Hospital
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015/1475
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.